Discoloration of Endosequence and Mineral Trioxde Aggregate in Revascularization of Necrotic Immature Permanent Teeth

Cairo University (CU) logo

Cairo University (CU)

Status

Not yet enrolling

Conditions

Pulp Necrosis

Treatments

Other: Revascularization

Study type

Interventional

Funder types

Other

Identifiers

NCT03813433
pedodontic department cairo

Details and patient eligibility

About

the objective of this study is to evaluate post operative pain after using Endosequence versus Mineral Trioxide Aggregate as coronal plug material in revascularization of non vital immature anterior teeth

Full description

The treatment of immature young permanent anterior teeth is challenging because in addition of the need of elimination of bacterial infection; the lack of natural apical constriction against which a suitable filling material can be placed is considered the main problem. In the past many different treatments have been proposed for immature permanent teeth with necrotic pulps such as:Custom fitting of filling materials like gutta percha, Periapical surgeries, apexification. The disadvantages of these treatments are: the compromised Crown/root ratio, possibility of vertical fracture. Pulp revascularization is dependent on the ability of residual pulp and apical and periodontal stem cells to differentiate. These cells have the ability to generate a highly vascularized and rich living tissue. MTA was chosen as coronal seal to be placed over the blood clot due its a biocompatibility, bio-inductivity. However, the disadvantages of MTA are: discoloration of the coronal dentine when placed in the canal and the difficult handling properties. Recently, a new bioceramic material has been introduced to the market, namely, EndoSequence which is bioactive, has antibacterial activity, less cytotoxic effect and similar antimicrobial properties, maintain color stability of the tooth when compared to MTA

Enrollment

24 estimated patients

Sex

All

Ages

8 to 14 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age of patient range from 8-14 y.
  • Patients are free from any systemic diseases that may hinder the normal healing process.
  • Non vital permanent anterior teeth with open apex.
  • Pulp space not needed for post and core for final restoration.
  • Compliant patient/parent.

Exclusion criteria

  • Patients having allergy to medicaments and antibiotics necessary to complete the procedure.
  • Tooth with vital pulp or complete root formation.
  • Teeth with internal or external root resorption.
  • Un-cooperative patients

Trial design

24 participants in 2 patient groups

Enosequence
Experimental group
Description:
3-4 mm of Endosequence will be applied over the blood clot in group I. Material will be packed using condenser with light pressure. Periapical radiograph will be taken to ensure coronal seal in the second visit of revascularization
Treatment:
Other: Revascularization
Mineral Trioxide Aggregate
Active Comparator group
Description:
3-4 mm of Mineral Trioxide Aggregate will be applied over the blood clot in group I. Material will be packed using condenser with light pressure. Periapical radiograph will be taken to ensure coronal seal in the second visit of revascularization
Treatment:
Other: Revascularization

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems